The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients

Context: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). Aims: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. Setting and Design: This was a cross-sect...

Full description

Bibliographic Details
Main Authors: Natasha Vijay Negalur, Gayatri G Ekbote, Dhiren N Raval, Dhaval V Tanna, Wasim S Kazi, Muzaffar A Bindroo, Durgarao J Yadavalli, Rajiva Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2021;volume=24;issue=4;spage=552;epage=558;aulast=Negalur
_version_ 1829502176010960896
author Natasha Vijay Negalur
Gayatri G Ekbote
Dhiren N Raval
Dhaval V Tanna
Wasim S Kazi
Muzaffar A Bindroo
Durgarao J Yadavalli
Rajiva Gupta
author_facet Natasha Vijay Negalur
Gayatri G Ekbote
Dhiren N Raval
Dhaval V Tanna
Wasim S Kazi
Muzaffar A Bindroo
Durgarao J Yadavalli
Rajiva Gupta
author_sort Natasha Vijay Negalur
collection DOAJ
description Context: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). Aims: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. Setting and Design: This was a cross-sectional observational study. Methods and Materials: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. Statistical Analysis: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. Results: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. Conclusion: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts.
first_indexed 2024-12-16T09:32:12Z
format Article
id doaj.art-4617bfd88bd641f2b6e801227179a5d2
institution Directory Open Access Journal
issn 0972-2327
1998-3549
language English
last_indexed 2024-12-16T09:32:12Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Indian Academy of Neurology
spelling doaj.art-4617bfd88bd641f2b6e801227179a5d22022-12-21T22:36:29ZengWolters Kluwer Medknow PublicationsAnnals of Indian Academy of Neurology0972-23271998-35492021-01-0124455255810.4103/aian.AIAN_1151_20The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patientsNatasha Vijay NegalurGayatri G EkboteDhiren N RavalDhaval V TannaWasim S KaziMuzaffar A BindrooDurgarao J YadavalliRajiva GuptaContext: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). Aims: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. Setting and Design: This was a cross-sectional observational study. Methods and Materials: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. Statistical Analysis: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. Results: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. Conclusion: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts.http://www.annalsofian.org/article.asp?issn=0972-2327;year=2021;volume=24;issue=4;spage=552;epage=558;aulast=Negalurantibodiesindianmda-5myositismyositis specific antibodiesnxp2tif1g
spellingShingle Natasha Vijay Negalur
Gayatri G Ekbote
Dhiren N Raval
Dhaval V Tanna
Wasim S Kazi
Muzaffar A Bindroo
Durgarao J Yadavalli
Rajiva Gupta
The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
Annals of Indian Academy of Neurology
antibodies
indian
mda-5
myositis
myositis specific antibodies
nxp2
tif1g
title The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
title_full The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
title_fullStr The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
title_full_unstemmed The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
title_short The association of myositis specific antibodies in patients with inflammatory myositis: Preliminary data in Indian patients
title_sort association of myositis specific antibodies in patients with inflammatory myositis preliminary data in indian patients
topic antibodies
indian
mda-5
myositis
myositis specific antibodies
nxp2
tif1g
url http://www.annalsofian.org/article.asp?issn=0972-2327;year=2021;volume=24;issue=4;spage=552;epage=558;aulast=Negalur
work_keys_str_mv AT natashavijaynegalur theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT gayatrigekbote theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT dhirennraval theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT dhavalvtanna theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT wasimskazi theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT muzaffarabindroo theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT durgaraojyadavalli theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT rajivagupta theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT natashavijaynegalur associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT gayatrigekbote associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT dhirennraval associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT dhavalvtanna associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT wasimskazi associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT muzaffarabindroo associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT durgaraojyadavalli associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT rajivagupta associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients